内分泌系医薬品の世界市場 2023-2027

当レポートでは内分泌系医薬品の市場規模は、2023年から2027年にかけて365億5,124万米ドル、予測期間中のCAGRは7.82%で成長すると予測しています。当レポートでは、内分泌系医薬品市場の全体分析、市場規模と予測、動向、成長促進要因・課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。

現在の世界の市場動向と促進要因、市場全体の環境に関する最新の分析を提供しています。

内分泌疾患の発生率の増加、内分泌学の有望なパイプライン、新規製剤やドラッグデリバリーシステムの研究などが市場を牽引しています。

本調査では、肥満と内分泌疾患の関連性が、今後数年間の内分泌系医薬品市場の成長を牽引する主要な理由の1つであると位置づけています。また、内分泌疾患に対するバイオシミラーの使用と老年人口の増加が、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 2017年から2021年の世界の内分泌系医薬品市場
• 治療領域セグメント分析2017-2021
• 流通チャネルセグメント分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 治療領域別の市場セグメンテーション

• 市場内訳
• 治療領域別比較
• 糖尿病薬 - 市場規模と予測 2022-2027
• hGH - 市場規模と予測 2022-2027
• 甲状腺ホルモン障害 - 市場規模と予測 2022-2027
• その他 - 市場規模と予測 2022-2027
• 治療領域別の市場機会

第7章 流通チャネル別市場セグメンテーション

• 市場内訳
• 流通チャネル別比較
• 病院薬局 - 市場規模と予測 2022-2027
• 小売薬局 - 市場規模と予測 2022-2027
• オンライン薬局 - 市場規模と予測 2022-2027
• 流通チャネル別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• 中国 - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Acerus Pharmaceuticals Corp.
• Bayer AG
• Beta Cell NV
• Eli Lilly and Co.
• Endo International Plc
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Hanmi Pharm Co. Ltd.
• Ipsen Pharma
• Merck and Co. Inc.
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global endocrinology drugs market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Therapy Area Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
• Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Therapy Area
• Exhibits33: Data Table on Comparison by Therapy Area
• Exhibits34: Chart on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Diabetes drugs - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Diabetes drugs - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on hGH - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on hGH - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on hGH - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on hGH - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by Therapy Area ($ million)
• Exhibits51: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits52: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits53: Chart on Comparison by Distribution Channel
• Exhibits54: Data Table on Comparison by Distribution Channel
• Exhibits55: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits56: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits58: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits67: Market opportunity by Distribution Channel ($ million)
• Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits71: Chart on Geographic comparison
• Exhibits72: Data Table on Geographic comparison
• Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits109: Market opportunity By Geographical Landscape ($ million)
• Exhibits110: Impact of drivers and challenges in 2022 and 2027
• Exhibits111: Overview on Criticality of inputs and Factors of differentiation
• Exhibits112: Overview on factors of disruption
• Exhibits113: Impact of key risks on business
• Exhibits114: Vendors covered
• Exhibits115: Matrix on vendor position and classification
• Exhibits116: Acerus Pharmaceuticals Corp. - Overview
• Exhibits117: Acerus Pharmaceuticals Corp. - Product / Service
• Exhibits118: Acerus Pharmaceuticals Corp. - Key offerings
• Exhibits119: Bayer AG - Overview
• Exhibits120: Bayer AG - Business segments
• Exhibits121: Bayer AG - Key offerings
• Exhibits122: Bayer AG - Segment focus
• Exhibits123: Beta Cell NV - Overview
• Exhibits124: Beta Cell NV - Product / Service
• Exhibits125: Beta Cell NV - Key offerings
• Exhibits126: Eli Lilly and Co. - Overview
• Exhibits127: Eli Lilly and Co. - Product / Service
• Exhibits128: Eli Lilly and Co. - Key offerings
• Exhibits129: Endo International Plc - Overview
• Exhibits130: Endo International Plc - Business segments
• Exhibits131: Endo International Plc - Key news
• Exhibits132: Endo International Plc - Key offerings
• Exhibits133: Endo International Plc - Segment focus
• Exhibits134: F. Hoffmann La Roche Ltd. - Overview
• Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits136: F. Hoffmann La Roche Ltd. - Key news
• Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits139: GlaxoSmithKline Plc - Overview
• Exhibits140: GlaxoSmithKline Plc - Business segments
• Exhibits141: GlaxoSmithKline Plc - Key offerings
• Exhibits142: GlaxoSmithKline Plc - Segment focus
• Exhibits143: Hanmi Pharm Co. Ltd. - Overview
• Exhibits144: Hanmi Pharm Co. Ltd. - Product / Service
• Exhibits145: Hanmi Pharm Co. Ltd. - Key offerings
• Exhibits146: Ipsen Pharma - Overview
• Exhibits147: Ipsen Pharma - Business segments
• Exhibits148: Ipsen Pharma - Key offerings
• Exhibits149: Ipsen Pharma - Segment focus
• Exhibits150: Merck and Co. Inc. - Overview
• Exhibits151: Merck and Co. Inc. - Business segments
• Exhibits152: Merck and Co. Inc. - Key news
• Exhibits153: Merck and Co. Inc. - Key offerings
• Exhibits154: Merck and Co. Inc. - Segment focus
• Exhibits155: Novartis AG - Overview
• Exhibits156: Novartis AG - Business segments
• Exhibits157: Novartis AG - Key offerings
• Exhibits158: Novartis AG - Segment focus
• Exhibits159: Novo Nordisk AS - Overview
• Exhibits160: Novo Nordisk AS - Business segments
• Exhibits161: Novo Nordisk AS - Key offerings
• Exhibits162: Novo Nordisk AS - Segment focus
• Exhibits163: Pfizer Inc. - Overview
• Exhibits164: Pfizer Inc. - Product / Service
• Exhibits165: Pfizer Inc. - Key news
• Exhibits166: Pfizer Inc. - Key offerings
• Exhibits167: Sanofi SA - Overview
• Exhibits168: Sanofi SA - Business segments
• Exhibits169: Sanofi SA - Key news
• Exhibits170: Sanofi SA - Key offerings
• Exhibits171: Sanofi SA - Segment focus
• Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits176: Inclusions checklist
• Exhibits177: Exclusions checklist
• Exhibits178: Currency conversion rates for US$
• Exhibits179: Research methodology
• Exhibits180: Validation techniques employed for market sizing
• Exhibits181: Information sources
• Exhibits182: List of abbreviations

Technavio has been monitoring the endocrinology drugs market and is poised to grow by $36551.24 mn from 2023-2027, accelerating at a CAGR of 7.82% during the forecast period. Our report on the endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the incidence of endocrine disorders, a promising pipeline for endocrinology, and research in novel dosage formulations and drug delivery systems.

Technavio's endocrinology drugs market is segmented as below:

By Therapy Area

• Diabetes drugs
• HGH
• Thyroid hormone disorders
• Others

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the association between obesity and endocrine disorders as one of the prime reasons driving the endocrinology drugs market growth during the next few years. Also, the use of biosimilars for endocrine disorders and the growing geriatric population will lead to sizable demand in the market.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the endocrinology drugs market covers the following areas:

• Endocrinology drugs market sizing
• Endocrinology drugs market forecast
• Endocrinology drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading endocrinology drugs market vendors that include Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC. Also, the endocrinology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global endocrinology drugs market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global endocrinology drugs market 2017 - 2021 ($ million)
• 4.2 Therapy Area Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Therapy Area Segment 2017 - 2021 ($ million)
• 4.3 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy Area

• 6.1 Market segments
• Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
• 6.2 Comparison by Therapy Area
• Exhibit 32: Chart on Comparison by Therapy Area
• Exhibit 33: Data Table on Comparison by Therapy Area
• 6.3 Diabetes drugs - Market size and forecast 2022-2027
• Exhibit 34: Chart on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Diabetes drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Diabetes drugs - Year-over-year growth 2022-2027 (%)
• 6.4 hGH - Market size and forecast 2022-2027
• Exhibit 38: Chart on hGH - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on hGH - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on hGH - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on hGH - Year-over-year growth 2022-2027 (%)
• 6.5 Thyroid hormone disorders - Market size and forecast 2022-2027
• Exhibit 42: Chart on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
• 6.6 Others - Market size and forecast 2022-2027
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by Therapy Area
• Exhibit 50: Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 51: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 52: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 53: Chart on Comparison by Distribution Channel
• Exhibit 54: Data Table on Comparison by Distribution Channel
• 7.3 Hospital pharmacies - Market size and forecast 2022-2027
• Exhibit 55: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• 7.4 Retail pharmacies - Market size and forecast 2022-2027
• Exhibit 59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• 7.5 Online pharmacies - Market size and forecast 2022-2027
• Exhibit 63: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 67: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 112: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 114: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 115: Matrix on vendor position and classification
• 12.3 Acerus Pharmaceuticals Corp.
• Exhibit 116: Acerus Pharmaceuticals Corp. - Overview
• Exhibit 117: Acerus Pharmaceuticals Corp. - Product / Service
• Exhibit 118: Acerus Pharmaceuticals Corp. - Key offerings
• 12.4 Bayer AG
• Exhibit 119: Bayer AG - Overview
• Exhibit 120: Bayer AG - Business segments
• Exhibit 121: Bayer AG - Key offerings
• Exhibit 122: Bayer AG - Segment focus
• 12.5 Beta Cell NV
• Exhibit 123: Beta Cell NV - Overview
• Exhibit 124: Beta Cell NV - Product / Service
• Exhibit 125: Beta Cell NV - Key offerings
• 12.6 Eli Lilly and Co.
• Exhibit 126: Eli Lilly and Co. - Overview
• Exhibit 127: Eli Lilly and Co. - Product / Service
• Exhibit 128: Eli Lilly and Co. - Key offerings
• 12.7 Endo International Plc
• Exhibit 129: Endo International Plc - Overview
• Exhibit 130: Endo International Plc - Business segments
• Exhibit 131: Endo International Plc - Key news
• Exhibit 132: Endo International Plc - Key offerings
• Exhibit 133: Endo International Plc - Segment focus
• 12.8 F. Hoffmann La Roche Ltd.
• Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
• 12.9 GlaxoSmithKline Plc
• Exhibit 139: GlaxoSmithKline Plc - Overview
• Exhibit 140: GlaxoSmithKline Plc - Business segments
• Exhibit 141: GlaxoSmithKline Plc - Key offerings
• Exhibit 142: GlaxoSmithKline Plc - Segment focus
• 12.10 Hanmi Pharm Co. Ltd.
• Exhibit 143: Hanmi Pharm Co. Ltd. - Overview
• Exhibit 144: Hanmi Pharm Co. Ltd. - Product / Service
• Exhibit 145: Hanmi Pharm Co. Ltd. - Key offerings
• 12.11 Ipsen Pharma
• Exhibit 146: Ipsen Pharma - Overview
• Exhibit 147: Ipsen Pharma - Business segments
• Exhibit 148: Ipsen Pharma - Key offerings
• Exhibit 149: Ipsen Pharma - Segment focus
• 12.12 Merck and Co. Inc.
• Exhibit 150: Merck and Co. Inc. - Overview
• Exhibit 151: Merck and Co. Inc. - Business segments
• Exhibit 152: Merck and Co. Inc. - Key news
• Exhibit 153: Merck and Co. Inc. - Key offerings
• Exhibit 154: Merck and Co. Inc. - Segment focus
• 12.13 Novartis AG
• Exhibit 155: Novartis AG - Overview
• Exhibit 156: Novartis AG - Business segments
• Exhibit 157: Novartis AG - Key offerings
• Exhibit 158: Novartis AG - Segment focus
• 12.14 Novo Nordisk AS
• Exhibit 159: Novo Nordisk AS - Overview
• Exhibit 160: Novo Nordisk AS - Business segments
• Exhibit 161: Novo Nordisk AS - Key offerings
• Exhibit 162: Novo Nordisk AS - Segment focus
• 12.15 Pfizer Inc.
• Exhibit 163: Pfizer Inc. - Overview
• Exhibit 164: Pfizer Inc. - Product / Service
• Exhibit 165: Pfizer Inc. - Key news
• Exhibit 166: Pfizer Inc. - Key offerings
• 12.16 Sanofi SA
• Exhibit 167: Sanofi SA - Overview
• Exhibit 168: Sanofi SA - Business segments
• Exhibit 169: Sanofi SA - Key news
• Exhibit 170: Sanofi SA - Key offerings
• Exhibit 171: Sanofi SA - Segment focus
• 12.17 Takeda Pharmaceutical Co. Ltd.
• Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 176: Inclusions checklist
• Exhibit 177: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 178: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 179: Research methodology
• Exhibit 180: Validation techniques employed for market sizing
• Exhibit 181: Information sources
• 13.5 List of abbreviations
• Exhibit 182: List of abbreviations